Radioimmunotherapy of the GW-39 Human Colonic Tumor Xenograft with 131 I-labeled Murine Monoclonal Antibody to Carcinoembryonic Antigen

Cancer Research

Volumn 47, Issue 21, 1987, Pages 5672-5677

  Sharkey, Robert M ^a,d   Pykett, Mark J ^b   Siegel, Jeffry A ^c   Alger, Elizabeth A ^c   Primus, F James ^c   Goldenberg, David M ^c  

^a Center for Molecular Medicine   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY I 131;

ANIMAL EXPERIMENT; COLON CARCINOMA; GROWTH INHIBITION; HAMSTER; HUMAN; HUMAN CELL; NONHUMAN; RADIOIMMUNOTHERAPY; TUMOR XENOGRAFT;

ANIMAL; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; FEMALE; IODINE RADIOISOTOPES; MICE; NEOPLASM TRANSPLANTATION; RADIOTHERAPY DOSAGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HETEROLOGOUS; YTTRIUM RADIOISOTOPES;

EID: 0023567422     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Goldenberg, D. M., DeL, F. H., Kim, E. E., Bennett, S., Primus, F. J., van Nagel, P., Jr., Estes, N., DeSimone, P., and Rayburn, P. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N. Engl. J. Med., 298: 1384-1388,1978.
2. Goldenberg, D. M., Kim, E. E., and DeLand, F. H. Human chorionic gonadotropic radioantibodies in the radioimmunodetection of cancer and for disclosure of occult metastases. Proc. Natl. Acad. Sci. USA, 78:7754-7758, 1981.
3. Pimm, M. V., Embleton, M. J., Perkins, A. C., Price, M. F., Robins, R. A., Robinson, G. R., and Baldwin, R. W. In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts. Int. J. Cancer, 30:75-85,1982.
4. Colcher, D., Zalutsky, M., Kaplan, W. M., Kufe, D., Austin, M. F., and Schlom, J. Radiolocalization of human mammary tumors in athymic mice by monoclonal antibody. Cancer Res., 43:736-742, 1983.
5. Buraggi, G. L., Callegaro, L., Mariani, G., Turrin, A., Cascinelli, N., Attili, A., Bombarieri, E., Terno, M. G., Plassio, M. G., Dovis, M., Mazzuca, N., Natali, P. G., Scassellati, G. A., Rosa, U., and Ferrone, S. Imaging with 131I-labeled monoclonal antibodies to a high molecular weight melanoma associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments. Cancer Res., 45:3378-3387,1985.
6. Order, S. E., Klein, J. L., and Leichner, P. K. Anti-ferritin IgG antibody for isotopic cancer therapy. Oncology, 38:154-160,1981.
7. Leichner, P. K., Klein, J. L., Fishman, E. K., Siegelman, S. S., Ettinger, D. S., and Order, S. E. Comparative tumor dose from 131I-labeled polyclonal anti-ferritin, anti-AFP, and anti-CEA in primary liver cancers. Cancer Drug. Del., 1:321-328,1984.
8. Larson, S. M., Carrasquillo, J. A., Kroh, K. A., Brown, J. P., McGuffin, R. W., Fereno, J. M., Graham, M. M., Hill, L. D., Beaumier, P. L., Hellstrom, K. E., and Hellstrom, I. Localization of 131I-labeled p-97-specific Fab fragments in human melanoma as a basis for radiotherapy. J. Clin. Invest., 72: 2101-2114,1983.
9. Courtenay, Luch, N., Epenetos, A. A., Halman, K. E., Hooker, G., Hughes, J. M. B., Krausz, T., Lambert, J., Lavender, J. P. G., McKenzie, C. J., Munro, A., Myers, M. J., Orr, J. S., Pearse, E. E., Snook, D., Webb, B., Burchell, J., Durbin, H., Kemshead, J., and Taylor-Papadimitrou, J. Anti-body-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. Lancet, II: 1441-1443,1984.
10. Sears, H. F., Herlyn, D., Steplewski, Z., and Koprowski, H. Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma. Cancer Res., 45:5910-5913,1985.
11. Houghton, A. N., Mintzer, D., Cardon-Cardo, C., Welt, S., Fliegel, B., Cadhan, S., Carswell, E., Melamed, M. R., Oettgen, H. F., and Old, L. Mouse monoclonal IgG3antibody detection GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc. Natl. Acad. Sci. USA, 82:1242-1246,1985.
12. Goldenberg, D. M., Gaffar, S. A., Bennett, S. J., and Beach, J. L. Experimental radioimmunotherapy of xenografted human colonic tumor (GW-39) producing carcinoembryonic antigen. Cancer Res., 41:4354-4360,1981.
13. Zalcberg, J. R., Thompson, C. H., Lichtenstein, M., and McKenzie, I. F. C. Tumor immunotherapy in the mouse with the use of 131I-labeled monoclonal antibodies. J. Natl. Cancer Inst., 72:697-704,1984.
14. Badger, C. C., Kroh, K. A., Shulman, H., Flournoy, N., and Berstein, I. D. 131I-labeled anti-T-cell antibodies. Cancer Res., 46:6223-6228,1986.
15. Cheung, N.-K. V., Landmeier, B., Neely, J., Nelson, A. D., Abramowsky, C., Ellory, S., Adams, R. B., and Miraldi, F. Complete tumor ablation with iodine-131 -radiolabeled desialoganglioside GD2-specifk monoclonal antibody against human neuroblastoma xenografted in nude mice. J. Natl. Cancer Inst., 77; 739-745,1986.
16. Primus, F. J., Newell, K. S., Blue, A., and Goldenberg, D. M. Immunological heterogeneity of carcinoembryonic antigen: antigen determinants on carcinoembryonic antigen distinguished by monoclonal antibodies. Cancer Res., 43:686-692,1983.
17. McConahey, P. J., and Dixon, F. J. A method of trace iodination of proteins for immunologic studies. Int. Arch. Allergy, 29:185-189,1966.
18. Goldenberg, D. M., and Hansen, H. J. Carcinoembryonic antigen present in human colonic neoplasia serially propagated in hamsters. Science (Wash. DC), 175: 1117–1118, 1972.
19. Goldenberg, D. M., and Ammersdorfer, E. Synergistic effects of X-rays and drugs on a human tumor xenograft. Eur. J. Cancer, 6:73-80,1970.
20. Primus, F. J., MacDonald, R., Goldenberg, D. M., and Hansen, H. J. Localization of GW-39 human tumors in hamsters by affinity-purified antibody to carcinoembryonic antigen. Cancer Res., 37; 1544-1547,1977.
21. Brownell, G. L., Ellett, W. H., and Reddy, A. R. Absorbed fractions for photon dosimetry. MIRD Pamphlet No. 3. J. Nucl. Med., 9 (Suppl. 1); 27-39,1968.
22. Synder, W. S., Ford, M. R., and Werner, G. G. “S” absorbed dose per amount of cumulative activity for selected radionuclides and organs. MIRD Pamphlet No. 11. New York: Society of Nuclear Medicine, 1975.
23. Dillman, L. T., and von der Lage, F. C. Radionuclide decay schemes and nuclear parameters for use in radiation dose estimation. MIRD Pamphlet No. 10. New York: Society of Nuclear Medicine, 1975.
24. Ellet, W. H., and Humes, R. M. Absorbed fractions for small volumes containing photon-emitting radioactivity. MIRD Pamphlet No. 8. J. Nucl. Med., 12 (Suppl. 5); 25-32,1971.
25. Sokal, R. R., and Rohlf, F. J. (Eds.) Biometry. San Francisco: W. H. Freeman and Company, 1969.
26. Primus, F. J., Sharkey, R. M., and Goldenberg, D. M. Radioimmunotherapy of human colcnic carcinoma xenografts with monoclonal and polyclonal antibodies to carcinoembryonic antigen. Proc. Am. Assoc. Cancer Res., 27: 336, 1986.
27. Bergen, M. J. Beta-ray dosimetry calculations with the use of point kernels. In: R. J. Cloutier, C. L. Edwards, and W. S. Snyder, (eds.), Medical Radionuclides: Radiation Dose and Effects pp. 63–68. Oak Ridge, TN: U.S. Atomic Energy Commission, 1970.
28. Kwok, C. S., Prestwich W. V., and Wilson, B. C. Calculation of radiation doses for nonuniformly distributed beta and gamma radionuclides in soft tissue. Med. Phys., 12:405-412,1985.
29. Fand, I., Sharkey, R. M., McNally, W. P., Brill, A. B., Som, P., Yamamoto, K., Primus, F. J., and Goldenberg, D. M. Quantitative whole-body autoradiography of radiolabeled antibody distribution in a xenografted human cancer model. Cancer Res., 46:271-277,1986.
30. Moshakis, V., McLlhinney, R. A. J., Raghavan, D., and Neville, A. M. Localization of human tumor xenografts after i.v. administration of radiolabeled monoclonal antibodies. Br. J. Cancer, 44:91-99,1981.
31. Sharkey, R. M., Primus, F. J., and Goldenberg, D. M. Antibody protein dose and radioimmunodetection of GW-39 human colon tumor xenografts. Int. J. Cancer, 39:611-617,1987.
32. DeJager, R. L., Primus, F. J., Ford, E. H., Mahal, P. S., Bapat, A. R., Alger, E. A., and Goldenberg, D. M. Phase I clinical trial of radioimmunotherapy with 131I labeled anti-CEA or anti-AFP in solid tumors producing CEA or AFP. Proc. Am. Soc. Clin. Oncol., 4; 224,1985.
33. Fawwaz, R. A., Wang, T. S. T., Srivastava, S. C., and Hardy, M. A. The use of radionuclides for tumor therapy. Nucl. Med. Biol., 13:429-436,1986.
34. Hnatowich, D. J., Virai, F., and Doherty, P. W. DTPA-coupled antibodies labeled with yttrium-90. J. Nucl. Med., 26:503-509,1985.
35. Vaughan, A. T. M., Keeling, A., and Yankuba, S. C. S. The production and biological distribution of yttrium-90-labeled antibodies. Int J. Appl. Radiat. Isot, 36:803-806,1985.
36. Washburn, T. T., Hwa-Sun, T. T., Crook, J. W., Byrd, B. C., Carlton, J. E., Hung, Y.-W., and Steplewski, Z. S. Y-90-labeled monoclonal antibodies for cancer therapy. Nucl. Med. Biol. 13:453-456.
37. Anderson-Berg, W. T., Squire, R. A., and Strand, M. Specific radioimmunotherapy using “Y-labeled monoclonal antibody. Cancer Res., 47; 1905–1912, 1987.